Detection, characterisation and purification of a murine liver factor capable of desensitising towards the lethal activity of tumour necrosis factor

Cytokine

Volumn 15, Issue 2, 2001, Pages 59-65

  Wielockx, B ^a   Hochepied, T ^a   Staelens, J ^a   Van Molle, W ^a   Brouckaert, P ^a   Libert, C ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Inflammation; Lethality; Liver purification; Septic shock

Indexed keywords

ASPARTATE AMINOTRANSFERASE; ENDOTOXIN; GALACTOSAMINE; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; LIVER EXTRACT; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DESENSITIZATION; DRUG EFFECT; DRUG PURIFICATION; ENZYME RELEASE; FEMALE; HYPOTHERMIA; LETHALITY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; MURINAE;

EID: 0035554827     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2001.0912     Document Type: Article

References (18)

1. Isolated limb perfusion for malignant melanoma
2. The pathophysiology of tumour necrosis factors
3. Tumour necrosis factor and lymphotoxin
4. Cytokines in rheumatoid arthritis: Trials and tribulations
5. Cytokines and inflammatory bowel disease
6. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release
7. Protection by alpha 1-acid glycoprotein against tumour necrosis factor-induced lethality
8. alpha1-Antitrypsin inhibits the lethal response to TNF in mice
9. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
10. Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced uniform sensitivity
11. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding
12. Involvement of the liver, but not of IL-6, in IL-1-induced desensitisation to the lethal effects of tumour necrosis factor
13. Biologic therapy with TNF: Preclinical studies
14. The cytokine storm in multiple sclerosis
15. Sensitisation and desensitisation to lethal effects of tumour necrosis factor and IL-1
16. Human recombinant interleukin-1 alpha protection against the lethality of endotoxin and experimental sepsis in mice
17. An overview on interleukin-1 as a therapeutic agent
18. Non-specific resistance mechanisms to listeriosis: Implications for experimental and naturally occurring infection